U.S. Sterile Injectable Contract Manufacturing Market Size & Outlook
The sterile injectable contract manufacturing market in the United States is expected to reach a projected revenue of US$ 9,260.0 million by 2030. A compound annual growth rate of 12.2% is expected of the United States sterile injectable contract manufacturing market from 2024 to 2030.
Revenue, 2023 (US$M)
$4,148.9
Forecast, 2030 (US$M)
$9,260.0
CAGR, 2024 - 2030
12.2%
Report Coverage
U.S.
U.S. sterile injectable contract manufacturing market, 2018-2030 (US$M)
Related Markets
U.S. sterile injectable contract manufacturing market highlights
- The U.S. sterile injectable contract manufacturing market generated a revenue of USD 4,148.9 million in 2023 and is expected to reach USD 9,260.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 12.2% from 2024 to 2030.
- In terms of segment, large molecule was the largest revenue generating molecule type in 2023.
- Large Molecule is the most lucrative molecule type segment registering the fastest growth during the forecast period.
Sterile injectable contract manufacturing market data book summary
| Market revenue in 2023 | USD 4,148.9 million |
| Market revenue in 2030 | USD 9,260.0 million |
| Growth rate | 12.2% (CAGR from 2023 to 2030) |
| Largest segment | Large molecule |
| Fastest growing segment | Large Molecule |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
| Key market players worldwide | Baxter International Inc, Catalent Inc, Recipharm, Fresenius SE & Co KGaA, Cipla Ltd DR |
Other key industry trends
- In terms of revenue, U.S. accounted for 28.9% of the global sterile injectable contract manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. sterile injectable contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 9,260.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sterile Injectable Contract Manufacturing Market Scope
Sterile injectable contract manufacturing market segmentation & scope
Others
Sterile Injectable Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. sterile injectable contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sterile injectable contract manufacturing market will help companies and investors design strategic landscapes.
Large molecule was the largest segment with a revenue share of 61.42% in 2023. Horizon Databook has segmented the U.S. sterile injectable contract manufacturing market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Sterile Injectable Contract Manufacturing Molecule Type Outlook (Revenue, USD Million, 2018-2030)
- Small Molecule
- Large Molecule
- U.S. Sterile Injectable Contract Manufacturing Therapeutic Application Outlook (Revenue, USD Million, 2018-2030)
- Cancer
- Diabetes
- Cardiovascular Diseases
- Central Nervous Systems Diseases
- Infectious Disorders
- Musculoskeletal
- Anti-Viral
- Others
- U.S. Sterile Injectable Contract Manufacturing Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Subcutaneous (SC)
- Intravenous (IV)
- Intramuscular (IM)
- Others
- U.S. Sterile Injectable Contract Manufacturing End Use Outlook (Revenue, USD Million, 2018-2030)
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others
Reasons to subscribe to U.S. sterile injectable contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. sterile injectable contract manufacturing market databook
-
Our clientele includes a mix of sterile injectable contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. sterile injectable contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. sterile injectable contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. sterile injectable contract manufacturing market size, by molecule type, 2018-2030 (US$M)
U.S. Sterile Injectable Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
